Case No. | Age (yr) | Sex | Disease | Location of Tumor | Duration (mo) from GK to MRP | Necrosis/Recurrence | Radiation Dosea by GK |
---|---|---|---|---|---|---|---|
1 | 45 | F | Lung ca. | Rt. temporal | 24 | Necrosis | 90%, 22 Gy |
Lt. cerebellum | 18 | Recurrence | 54%, 22 Gy | ||||
2 | 64 | M | Lung ca. | Rt. cerebellum | 25 | Necrosis | 70%, 21 Gy |
3 | 70 | F | Lung ca. | Lt. occipital | 25 | Necrosis | 60%, 22 Gy |
4 | 75 | M | Lung ca. | Lt. frontal | 4 | Necrosis | 60%, 22 Gy |
5 | 78 | M | Lung ca. | Lt. occipital | 14 | Necrosis | 55%, 20 Gy |
6 | 64 | M | Renal cell ca. | Lt. frontal | 34 | Necrosis | 58%, 20 Gy |
Rt. cerebellum | 18 | Recurrence | 55%, 20 Gy | ||||
7 | 56 | F | Breast ca. | Midbrain | 35 | Necrosis | 57%, 20 Gy |
8 | 68 | M | Lung ca. | Rt. parietal | 52 | Necrosis | 55%, 21 Gy |
9 | 76 | M | Lung ca. | Lt. occipital | 30 | Recurrence | 65%, 22 Gy |
10 | 42 | F | Breast ca. | Rt. frontal | 52 | Recurrence | 80%, 20 Gy |
11 | 75 | F | Lung ca. | Rt. temporal | 6 | Recurrence | 55%, 22 Gy |
12 | 60 | M | Lung ca. | Lt. frontal | 14 | Recurrence | 52%, 20 Gy |
Lt. frontal | 22 | Recurrence | 52%, 20 Gy | ||||
13 | 63 | M | Lung ca. | Lt. frontal | 14 | Recurrence | 53%, 20 Gy |
14 | 54 | F | Ovarian ca. | Rt. parietal | 7 | Recurrence | 54%, 32 Gy |
15 | 59 | M | Lung ca. | Lt. frontal | 16 | Recurrence | 50%, 18 Gy |
Note:âRt indicates right; Lt, left; ca., carcinoma; MRP, MR permeability imaging.
âµa A prescription dose of 18â32 Gy at 50%â90% isodose.